Winston-Salem, N.C.-based Wake Forest School of Medicine received a $30 million, five-year federal grant to study cardiac rehabilitation for patients with heart failure, the Winston-Salem Journal reported Oct. 10.
Uncategorized
Here are four cardiologists who have stepped into new roles since Oct. 6:
Biotechnology company RadioMedix has raised $40 million in series A funding; the company plans to use the new funding to advance its flagship radiopharmaceutical, AlphaMedix.
Value-based care models and arrangements keep evolving. With CMS preparing to upgrade its current value-based Oncology Care Model (OCM) to the Enhancing Oncology Model (EOM), cancer centers are keen for insights that can help them participate and be successful.
Tulsa-based Oklahoma Heart Institute cardiologists were the first in the world to use a new heart valve implant, News on 6 reported Oct. 7.
Los Angeles-based Cedars-Sinai Cancer is welcoming nine oncology specialists to its affiliate, Huntington Cancer Center in Pasadena, Calif.
American Oncology Network entered into a definitive business combination agreement with Digital Transformation Opportunities Corp. and will become a public company.
New cancer vaccine research shines a positive light on the possibility of cancer vaccines. Three new vaccines are being studied in patients with pancreatic and breast cancer and colon polyps, The New York Times reported Oct. 10.
A landmark study suggests colonoscopies are not as effective as previously thought, though they can still help some.
Here are five oncology firsts Becker's has covered since Sept. 12: